Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Sponsor
Li Xiaorong
Study ID
NCT06478407
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Study Details

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ，improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

Key Dates

First listed
Jun 27, 2024
Start date
Mar 28, 2024
Status verified
Jul 2024
Primary completion
Mar 28, 2025
Completion
Mar 28, 2025

Study Design

Enrollment
18,000 participants (estimated)

Arms

  • Arm: Diabetic retinopathy screening group
    Diabetes patients in the community to accept unified eye test, confirm whether patients with diabetic retinopathy

Primary Outcome Measure

Classification of diabetic retinopathy [ Time Frame: At screening ]

Central Contacts

Find similar trials

Nationwide
Diabetic retinopathy trialsOphthalmology trialsRetina trials

Related Studies